First Trust Advisors »

Taysha Gene Therapies shares owned by First Trust Advisors

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by First Trust Advisors from 13F filings

Historical chart of First Trust Advisors investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by First Trust Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by First Trust Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.4M 791k 6.81

More positions owned by First Trust Advisors

Cisco Systems (CSCO)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Palo Alto Networks (PANW)
Applied Materials (AMAT)
Microsoft Corporation (MSFT)
Apple (AAPL)
Fortinet (FTNT)
Kla Corp Com New (KLAC)
Lam Research Corp Com New (LRCX)
Crowdstrike Hldgs Cl A (CRWD)
Quanta Services (PWR)
Eaton Corp SHS (ETN)
Micron Technology (MU)

View all positions for First Trust Advisors

Top funds holding Taysha Gene Therapies

venBio Select Advisor
RA Capital Management
Goldman Sachs Group
BlackRock
Vestal Point Capital
Morgan Stanley
Rtw Investments
FMR
Vanguard Capital Management
State Street Corporation
Siren
Octagon Capital Advisors
Geode Capital Management
Polar Capital Holdings
MPM Oncology Impact Management

View all funds holding Taysha Gene Therapies